$CLVT News

Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence

Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence

Clarivate (CLVT) Stock Looks Undervalued Despite Ongoing Caution Around Sales

Clarivate (CLVT) Could Be 40% Undervalued On Its AI Patent Partnership

Learn Why The Bull Case For Clarivate Stock Could Change Following AI Patent Tools Partnership

Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Clarivate (CLVT) Q2 2026 Earnings Call Transcript

Can Clarivate’s (CLVT) Agentic AI Push Deepen Its Moat Or Signal A Riskier Shift?

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Clarivate (CLVT) Price Target Decreased by 13.28% to 2.94

Citigroup Maintains Neutral on Clarivate, Lowers Price Target to $2.5

Goldman Sachs Maintains Neutral on Clarivate, Lowers Price Target to $2.6